To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
April 6, 2005
Gregory J. Hannon, PhD (Damon Runyon Fellow '92-'94) won the 2005 AACR Award for Outstanding Achievement in Cancer Research. He is a pioneer in the field of RNA interference (RNAi). One focus of his laboratory is to harness RNAi technology to search the human genome for novel therapeutic targets for cancer.
David Livingston, MD (Damon Runyon Board Member) was the winner of the 2005 AACR-G.H.A. Clowes Memorial Award. The award, sponsored by Eli Lilly and Company, recognizes outstanding recent accomplishments in basic cancer research.
---
James J. Manfredi, PhD (Damon Runyon Fellow '83-'85) discounted the role of SV40 virus in malignant mesotheliomas (cancers associated with exposure to asbestos). The possibility that SV40 virus might contribute to this type of cancer came to light when it was discovered that polio vaccines widely used in the 1960's were contaminated with the virus.